Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03567616
Recruitment Status : Suspended (Safety)
First Posted : June 25, 2018
Last Update Posted : September 20, 2019
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
AbbVie

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : August 20, 2020
Estimated Study Completion Date : January 22, 2021